Schedule 13D ownership disclosure
AGEX THERAPEUTICS INC
Security class unavailable · CUSIP: 00848H108
Event date: 2022-04-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 68.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-044660
- Form type
- SC 13D
- Filer
- Serina Therapeutics, Inc.
- CIK
- CIK 1708599
- Filed
- Apr 11, 2022
- Reporting period
- Apr 04, 2022
- Description
- Schedule 13D beneficial ownership